Europeiska unionen - svenska - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Europeiska unionen - svenska - EMA (European Medicines Agency)

leo pharma a/s - tralokinumab - dermatit, atopisk - andra dermatologiska preparat - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.

Europeiska unionen - svenska - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - andra dermatologiska preparat - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

mylan ab - imatinibmesilat - filmdragerad tablett - 100 mg - imatinibmesilat 119,5 mg aktiv substans - imatinib

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

mylan ab - imatinibmesilat - filmdragerad tablett - 400 mg - imatinibmesilat 478 mg aktiv substans - imatinib

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - vorikonazol - filmdragerad tablett - 200 mg - vorikonazol 200 mg aktiv substans; laktosmonohydrat hjälpämne - vorikonazol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - vorikonazol - pulver till infusionsvätska, lösning - 200 mg - vorikonazol 1 mg aktiv substans; sulfobutylbetadexnatrium hjälpämne - vorikonazol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - vorikonazol - pulver till oral suspension - 40 mg/ml - sackaros hjälpämne; vorikonazol 40 mg aktiv substans; natriumbensoat hjälpämne - vorikonazol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pfizer ab - vorikonazol - filmdragerad tablett - 50 mg - vorikonazol 50 mg aktiv substans; laktosmonohydrat hjälpämne - vorikonazol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

mylan ab - sorafenibtosilat - filmdragerad tablett - 200 mg - sorafenibtosilat 274 mg aktiv substans; natriumlaurilsulfat hjälpämne